medigraphic.com

2008, Número 3

<< Anterior Siguiente >>

Rev Hosp Jua Mex 2008; 75 (3)


Degenerative spondylolisthesis and joint disease in adult people

Rafael H

Idioma: Ingles.
Referencias bibliográficas: 50
Paginas: 218-222
Archivo PDF: 148.04 Kb.


RESUMEN

Con base en los hallazgos anatómicos, hormonales y patológicos en la columna y articulaciones periféricas en pacientes con cambios degenerativos, creo que ambos son causados por isquemia progresiva debida a aterosclerosis y deficiencia de hormona de crecimiento en nuestro cuerpo. Los cambios patológicos son iniciados en los discos intervertebrales (alrededor de 30 años) y varios años después (alrededor de 50 años), en las articulaciones periféricas. Por eso, en mi opinión, el tratamiento debe estar dirigido en contra de la aterosclerosis y terapia de sustitución con hormona de crecimiento.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ratcliffe JF. The anatomy of fourth and fifth lumbar arteries in humans: An arteriographic study in one hundred live subjects. J Anat 1982; 135: 735-61.

  2. Svensson HO, Vedin A, Wilhelmsson C, Andersson GB. Low back pain in relation to other diseases and cadiovascular risk factors. Spine 1883; 8: 277-85.

  3. Ratcliffe JF. The arterial anatomy of the developing human dorsal and lumbar vertebral body. A microarteriographic study. J Anat 1981; 133: 625-38.

  4. Texon M. The hemodynamic concept of atherosclerosis. Bull NY Acad Med 1960; 36: 263-74.

  5. Rogoff SM, Lipchik EO. Lumbar aortography in atherosclerosis. In: Abrams HL (ed.). Angiography. 2nd Ed. New York: Churchill Linvingstone; 1970, p. 737-57.

  6. Kurunlahi M, Tervonen O, Vanharanta H, Jikko E, Suramo I. Association of atherosclerosis with low back pain and the degree of disc degeneration. Spine 1999; 24: 2080-4.

  7. Rafael H. Low back pain. J Neurosurg 2007; 7(7): 114-6.

  8. Rafael H. Aortic atherosclerosis and lumbar spondylolisthesis. J Neurol Sci (Turk) 2007; 24(4): 260-2.

  9. Fawcett DW. A texbook of histology. Chapter 7. New York: Chapman & Hall; 1994, p. 182-93.

  10. Testud L, Latarjet A. Anatomía humana. Tomo I. Barcelona: Salvat Edit.; 1979, p. 1-43.

  11. De Palma AF, Rothman RH. The intervertebral disc. Chapter I. Philadelphia: W.W.Saunders Co.; 1971, p. 1-29.

  12. Rafael H, Ayulo V, Lucar A. Patogenia de la aterosclerosis: Base hemodinámica y factores de riesgo. Rev Climaterio 2003; 6(33): 125-8.

  13. Doiata M, Kanatanic T, Harada T, Mizuno K. Inmunohistologic atudy of the rupture intervertebral disc of the lumbar spine. Spine 1996; 21: 235-41.

  14. Rosenberg NJ. Degenerative spondylolisthesis. Clin Orthopaedic and Related Res 1976; 117: 112-20.

  15. Boleaga-Durán B, Fiesco-Gómez LE. Enfermedad degenerativa de la columna lumbosacra. Correlación clínica y por resonancia magnética. Cir Ciruj (Méx) 2006; 74(2): 101-5.

  16. Radin EL, Paul IL, Rose RM. Role of mechanical factors in pathogenesis of primary osteoarthritis. Lancet 1972; I: 519-21.

  17. Martyn CN, Greenwald SE. Impaired synthesis of elastine in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension. Lancet 1997; 350: 953-5.

  18. Ross R, Glonset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 1976; 295: 369-76.

  19. Komotar RJ, Wilson DA, Mocco J, et al. Natural history of intracranial atherosclerosis. Neurosurgery 2006; 58(4): 595-601.

  20. Hass WK, Field WS, North RR, Kricheff II, Chase NE, Bauer RB. Joint study of extracranial arterial occlusion II: Arteriographic, techniques, siters, and complications. JAMA 1968; 203: 961-8.

  21. Flora GC, Baker SAP, Loewenson RB, Klassen AC. A comparative study of cerebral atherosclerosis in males and females. Circulation 1968; 38: 859-69.

  22. Scharrer E, Gaupp R. Neuere befunde and nucleus supraopticus und nucleus paraventricularis des menschen. Z Neural 1933; 148: 766-72.

  23. Finley KH. The capillary bed of the paraventricular and supraoptic nuclei of the hypothalamus. Res Publ Ass Nerv Ment Dis 1938; 18: 94-109.

  24. Page RB, Bergland RM. The neurohypophyseal capillary bed. I. Anatomy and arterial supply. Am J Anat 1977; 148: 345-51.

  25. Felten DL, Crutcher KA. Neuronal-vascular relationships in the raphe nuclei, locus coeruleus and substantia nigra in primates. Am J Anat 1979; 155: 467-72.

  26. Martin JB. Neural regulation of growth hormone secretion. N Engl J Med 1973; 288: 1384-92.

  27. Rafael H. Rejuvenation after omental trasnplantation on the optic chiasma and carotid bifurcation. Case Rep Clin Pract Rev 2006; 7: 48-51.

  28. Rafael H. Stem cells. J Neurosurg 2008; 108(4): 841-2.

  29. Rudman D. Growth hormone, body composition and agin. J Anat Geriat Soc 1985; 33: 800-7.

  30. Vance ML. Growth hormone for the elderly? N Engl J Med 1990; 323: 52-4.

  31. Leal S, Andrade JP, Paula-Barobosa MM, Madeira MD. Arcuate nucleus of the hypothalamus. Effect of age and sex. J Comp Neurol 1998; 401: 65-88.

  32. Altman J. Are new neurons formed in the brain of adult mammal? Science 1962; 135: 1127-8.

  33. Altman J, Das GD. Autoradiographic and histological evidences of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965; 124: 319-36.

  34. Rietze RL, Bartlett PF. Purification of a pluripotent neural stem cells from adult mouse brain. Nature 2001; 412: 736-9.

  35. Rafael H, Fernández E, Ayulo V, Dávila L. Weight loss following omental transplantation on the anterior perforated space. Case Rep Clin Pract Rev 2003; 4(3): 160-2.

  36. Rafael H, Mego R, Moromizato P, García W, Rodriguez J. Omental transplantation forr type 2 diabetes mellitus: A report of two cases. Case Rep Clin Pract Rev 2004; 5: 481-48.

  37. Rafael H. Cerebral atherosclerosis and oxidative stress in some challenging diseases. J Neurol Sci (Turk) 2004; 21(4): 343-9.

  38. Blouin AM, Thannickal TC, Warly PF, Baraban JM, Reti IM, Siegel JM. Narp immunostaining of human hypocretin (orexin) neurons. Neurology 2005; 65(8): 1189-92.

  39. Rafael H. Hypothalamic ischemia and metabolic syndrome. Med Sci Monit 2006; 12(9): LE17-18.

  40. Rafael H. Isquemia hipotalámica y diabetes mellitus tipo 2. Rev Mex Cardiol 2007; 18(4): 185-7.

  41. Corpas E, Hatman SM, Blackman MR. Human growth hormone and human aging. Endocrine Rev 1993; 14: 20-39.

  42. Rudman D, Felle AG, Nagray HS, et al. Effects of human growth hormone in man over 60 years old. N Engl J Med 1990; 323: 1-6.

  43. Kerckoff H. Manejo de la somatotropina sintética anti-envejecimiento. Rev Climaterio 2004; 7(42): 245-9.

  44. Clemmons DR, Vyk JJ. Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab 1984; 13: 113-43.

  45. Morgan HE, Jefferson LS, Wolpert EB, Rannels DE. Regulation of protein synthesis in heart muscle. II Effects of aminoacid levels and insulin on ribosomal aggregation. J Biol Chem 1971; 246: 2163-70.

  46. Cheek DB, Hill DE. Effect of growth hormone on cell and somatic growth. In: Knobil E, Sawyer WH (eds.). Handbook of Pysiology. Sect 7. Vol 4. Am Physiol Soc 1974: 159-86.

  47. Parker ML, Hammond JM, Daughaday WH. The ariginine provocative test. An aid in diagnosis of hyposomatotropism. J Clin Endocrinol 1967; 27: 1129-36.

  48. Jeanloz BW. The nomenclature of acid mucopolysaccharides. Arthritis Rheum 1960; 3: 323-7.

  49. Verhoeven HC, De RL. Growth hormone replacement therapy: Is it safe? The Aging Male 2005; 8(2): 121-122 (Abstract).

  50. Rafael H. Hypothalamic ischemia and premature aging. Med Sci Monit 2007; 13(7): LE9-10.




2020     |     www.medigraphic.com